Phenotypic Variation of Autosomal-Dominant Corticobasal Degeneration
Author(s) -
Hans H. Jung,
Juliane Bremer,
Johannes Streffer,
Kanwar Virdee,
Maria Grazia Spillantini,
R. Anthony Crowther,
Peter Brugger,
Christine Van Broeckhoven,
Adriano Aguzzi,
Markus Tolnay
Publication year - 2012
Publication title -
european neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 77
eISSN - 1421-9913
pISSN - 0014-3022
DOI - 10.1159/000334731
Subject(s) - corticobasal degeneration , phenotype , variation (astronomy) , progressive supranuclear palsy , neuroscience , biology , genetics , psychology , gene , physics , astrophysics , atrophy
Neurodegenerative tauopathies may be inherited as autosomal-dominant disorders with variable clinicopathological phenotypes, and causative mutations in the microtubule-associated protein tau (MAPT) gene are not regularly seen. Herein, we describe a patient with clinically typical and autopsy-proven corticobasal degeneration (CBD). Her mother was diagnosed to have Parkinson's disease, but autopsy showed CBD pathology as in the index patient. The sister of the index patient had the clinical symptoms of primary progressive aphasia (PPA), but no pathology was available to date. Molecular analysis did not reveal any mutation in the MAPT or progranulin (GRN) genes. Our findings illustrate that CBD, progressive supranuclear palsy and PPA may be overlapping diseases with a common pathological basis rather than distinct entities. Clinical presentation and course might be determined by additional, yet unknown, genetic modifying factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom